Search

Your search keyword '"Busserolles, Jérôme"' showing total 187 results

Search Constraints

Start Over You searched for: Author "Busserolles, Jérôme" Remove constraint Author: "Busserolles, Jérôme"
187 results on '"Busserolles, Jérôme"'

Search Results

1. The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project)

3. Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project

7. Exploring Serum Biomarkers for Neuropathic Pain in Rat Models of Chemotherapy-Induced Peripheral Neuropathy: A Comparative Pilot Study with Oxaliplatin, Paclitaxel, Bortezomib, and Vincristine

15. Analgesic and preventive effects of donepezil in animal models of chemotherapy-induced peripheral neuropathy: Involvement of spinal muscarinic acetylcholine M2 receptors

16. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice

17. Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy

19. Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study

22. TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects

23. Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study

26. Testosterone‐androgen receptor: The steroid link inhibiting TRPM8‐mediated cold sensitivity

33. Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin

34. The Nav1.9 channel is crucial for sensing noxious cold

35. The Safety of Medications used to Treat Peripheral Neuropathic Pain, Part 2 (Opioids, Cannabinoids and Other Drugs): review of Double-Blind, Placebo-Controlled, Randomized Clinical Trials

36. Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity

37. New insight in cold pain: Role of ion channels, modulation, and clinical perspectives

38. The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia

39. Synthesis and structure-activity relationship study of substituted caffeateesters as antinociceptive agents modulating the TREK-1 channel

42. Le canal Nav1.9

43. Pharmacogenomics in pain treatment

45. The Nav1.9 Channel Is a Key Determinant of Cold Pain Sensation and Cold Allodynia

47. The transient receptor potential channel TRPM8 is inhibited via the alpha 2A adrenoreceptor signaling pathway.

48. Activation of TREK-1 by morphine results in analgesia without adverse side effects

49. Alleviating Pain Hypersensitivity through Activation of Type 4 Metabotropic Glutamate Receptor

Catalog

Books, media, physical & digital resources